Marije Slingerland

2.9k citations

88 papers · 1.4k indexed · h-index 19

Geriatrics and Gerontology top 5%
- Frailty in Older Adults 13
Otorhinolaryngology top 5%
- Head and Neck Cancer Studies 9
Biomaterials top 5%
Oncology top 10%
- Cancer Immunotherapy and Biomarkers 9
- Pancreatic and Hepatic Oncology Research 6
Pulmonary and Respiratory Medicine top 10%
- Gastric Cancer Management and Outcomes 33
- Lung Cancer Diagnosis and Treatment 7
Surgery
- Esophageal Cancer Research and Treatment 35
- Esophageal and GI Pathology 13

Co-authors: Hans Gelderblom Henk‐Jan Guchelaar Marc Diederich Simon P. Mooijaart Claudia Cerella Floor J. van Deudekom Rob H.A. Verhoeven Hanneke W.M. van Laarhoven
Cited by: Geriatrics and Gerontology Otorhinolaryngology Biomaterials
Journals: Journal of Clinical Oncology (8 papers)European Journal of Cancer (6 papers)Annals of Oncology (6 papers)
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Marije Slingerland

75 papers receiving 1.3k citations

Peers

Countries citing papers authored by Marije Slingerland

Since Specialization

Citations

This map shows the geographic impact of Marije Slingerland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marije Slingerland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marije Slingerland more than expected).

Fields of papers citing papers by Marije Slingerland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marije Slingerland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marije Slingerland. The network helps show where Marije Slingerland may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Marije Slingerland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marije Slingerland Line = papers co-authored together Marije Slingerland links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Impact of geriatric impairments on outcomes of single‐agent immunotherapy in solid tumors International Journal of Cancer ·Thimmaiah Chandrashekar,Karlijn de Joode,Ellen Kapiteijn,Marije Slingerland,Jeff Kennett,Frederiek van den Bos,Simon P. Mooijaart,広瀬侑,Stella Trompet,Hans M. Westgeest,Astrid A.M. van der Veldt,Ron H.J. Mathijssen,Geert Labots,Cynthia Holterhues,Els M.E. Verdegaal,Nienke A. de Glas,Johanneke E. A. Portielje	2025	0
2	Optimal timing for initiating first-line palliative systemic therapy in asymptomatic metastatic esophagogastric cancer: Insights from a European Delphi study European Journal of Cancer ·Liqin Cao,Anne M. May,Antoine Adenis,Andreia Capela,Sarah Derks,Nur Ain Syuhada Rohizan,Dominika Kosárová,Cinta Hierro,Aysegül Ilhan‐Mutlu,Florian Lordick,Radka Obermannová,Angelica Petrillo,Alberto Puccini,A.S. Tylakhmetova,Giandomenico Roviello,Falk,Marije Slingerland,Elizabeth Smyth,Hanneke W.M. van Laarhoven,Nadia Haj Mohammad	2025	1
3	A cost-effectiveness analysis of the effect of hospital variation in the probability of providing treatment with curative intent in potentially curable esophageal and gastric cancer patients. PubMed ·E N Gasanova,Pauline A. J. Vissers,Grard A. P. Nieuwenhuijzen,Maurice J.C. van der Sangen,Peter D. Siersema,Marije Slingerland,Sofía Romero-Santos,Laurens V. Beerepoot,Mark I. van Berge Henegouwen,Pieter C. van der Sluis,Camiel Rosman,Ewout A. Kouwenhoven,Hüseyin Aktaş,Hanneke W.M. van Laarhoven,Carin A. Uyl‐de Groot,Rob H.A. Verhoeven	2025	0
4	A Novel TRG-N Prognostic Classification System for Esophageal Cancer Undergoing Neoadjuvant Therapy Followed by Esophagectomy Annals of Surgery ·캠퍼스 HR사업부,Zhouqiao Wu,Rob H.A. Verhoeven,Lucas Goense,Nadia Haj Mohammad,Stella Mook,Peter S.N. van Rossum,Marije Slingerland,Jan Erik Freund,Jelle P. Ruurda,Richard van Hillegersberg	2025	0
5	DOSAGE study: protocol for a phase III non-inferiority randomised trial investigating dose-reduced chemotherapy for advanced colorectal cancer in older patients BMJ Open ·Gilvan José Campelo dos Santos,Frederiek van den Bos,Marije Slingerland,唐建新,Gerrit‐Jan Liefers,Wilbert B. van den Hout,Marta Fiocco,Arie J. Verschoor,J. L. Revilla,Cynthia Holterhues,Danny Houtsma,Anouk Jochems,R. Hardy,Leti van Bodegom‐Vos,Simon P. Mooijaart,Hans Gelderblom,Frank M. Speetjens,Nienke A. de Glas,Johanneke E. A. Portielje	2024	0
6	Blood based immune biomarkers associated with clinical frailty scale in older patients with melanoma receiving checkpoint inhibitor immunotherapy Immunity & Ageing ·Shalini Gupta,Saskia J. Santegoets,Simon P. Mooijaart,Diana van Heemst,Thimmaiah Chandrashekar,Els M.E. Verdegaal,Marije Slingerland,Ellen Kapiteijn,Sjoerd H. van der Burg,Johanneke E.A. Portielje,Marij J.P. Welters,Nienke A. de Glas	2024	2
7	Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastroesophageal Cancer Journal of the National Comprehensive Cancer Network ·M.J.M. van Velzen,Владислав Дмитриевич Слиж,Mirjam A. G. Sprangers,Jessy Joy van Kleef,Bianca Mostert,Laurens V. Beerepoot,Marije Slingerland,Elske C. Gootjes,Ronald Hoekstra,Lonneke V. van de Poll‐Franse,Nadia Haj Mohammad,Hanneke W.M. van Laarhoven	2024	2
8	438P Adjuvant nivolumab after neoadjuvant chemoradiotherapy and surgery for patients with esophageal or gastroesophageal junction cancer: A nationwide real-world matched comparison of overall survival Annals of Oncology ·Rob H.A. Verhoeven,Sally E. Schlak,Marije Slingerland,Bas P. L. Wijnhoven,Mark I. van Berge Henegouwen,Peter S.N. van Rossum,Sarah Derks,Bianca Mostert,Nadia Haj Mohammad,Hanneke W.M. van Laarhoven	2024	1
9	Assessing real-world representativeness of prospective registry cohorts in oncology: insights from patients with esophagogastric cancer Journal of Clinical Epidemiology ·Sally E. Schlak,Joost Besseling,Thomas Klausch,Marije Slingerland,Herlina Panjaitan,Ewout A. Kouwenhoven,Laurens V. Beerepoot,Nadia Haj Mohammad,Bastiaan Klarenbeek,Rob H.A. Verhoeven,Hanneke W.M. van Laarhoven	2023	2
10	Time trends in treatment patterns and survival of older patients with synchronous metastatic colorectal cancer in the Netherlands: A population‐based study International Journal of Cancer ·Gilvan José Campelo dos Santos,Nienke A. de Glas,Gerrit‐Jan Liefers,Marije Slingerland,Frank M. Speetjens,Frederiek van den Bos,J. L. Revilla,Arie J. Verschoor,Anouk Jochems,Datta Ashok Nalle,Cynthia Holterhues,Chang Richard Che-Shoa,Simon P. Mooijaart,Johanneke E.A. Portielje,Marloes G.M. Derks	2023	3
11	The association between hospital variation in curative treatment for esophagogastric cancer and health-related quality of life and survival European Journal of Surgical Oncology ·Pauline A. J. Vissers,守池澤,V.E.P.P. Lemmens,Hanneke W. M. van Laarhoven,Marije Slingerland,Bas P. L. Wijnhoven,Camiel Rosman,Stella Mook,Joos Heisterkamp,Ellen M. Hendriksen,Suzanne S. Gisbertz,Grard A. P. Nieuwenhuijzen,Rob H.A. Verhoeven	2023	1
12	Chemotherapy-Related Toxic Effects and Quality of Life and Physical Functioning in Older Patients JAMA Network Open ·Gilvan José Campelo dos Santos,Nienke A. de Glas,van Acken K,Fenghua Chen,Stella Trompet,広瀬侑,Himani Lalit,Geert Labots,Cynthia Holterhues,Jessica M. van der Bol,Raffaella Lamparelli,Gerrit‐Jan Liefers,Marije Slingerland,Frederiek van den Bos,Simon P. Mooijaart,Johanneke E.A. Portielje	2023	31
13	Geriatric assessment and treatment outcomes in a Dutch cohort of older patients with potentially curable esophageal cancer Acta Oncologica ·van Acken K,Stella Trompet,Floor J. van Deudekom,Barbara C. Van Munster,Nienke A. de Glas,Frederiek van den Bos,広瀬侑,Kun-Sik Park,Marleen A. E. van der Kaaij,Karen J. Neelis,Alexandra M. J. Langers,Marije Slingerland,Johanneke E. A. Portielje,Simon P. Mooijaart	2022	13
14	Design and rationale of a routine clinical care pathway and prospective cohort study in older patients needing intensive treatment BMC Geriatrics ·van Acken K,Floor J. van Deudekom,Stella Trompet,Iris Postmus,広瀬侑,Kun-Sik Park,Nienke A. de Glas,Diana van Heemst,Geert Labots,Yun-Feng 云峰 Ma 马,Marije Slingerland,Gerrit‐Jan Liefers,Frederiek van den Bos,Jessica M. van der Bol,Gerard J. Blauw,Johanneke E. A. Portielje,Simon P. Mooijaart	2021	16
15	Increased assessment of HER2 in metastatic gastroesophageal cancer patients: a nationwide population-based cohort study Gastric Cancer ·Willemieke P.M. Dijksterhuis,Rob H.A. Verhoeven,Sybren L. Meijer,Marije Slingerland,Nadia Haj Mohammad,Judith de Vos‐Geelen,Laurens V. Beerepoot,Theo van Voorthuizen,Geert‐Jan Creemers,Martijn G.H. van Oijen,Hanneke W.M. van Laarhoven	2020	19
16	The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer Clinical and Translational Radiation Oncology ·Gabi W. van Pelt,HMartin Northup,Irene M. Lips,Femke P. Peters,David van Klaveren,Jurjen J. Boonstra,Wobbe O. de Steur,Rob A.�E.�M. Tollenaar,Arantza Fariña Sarasqueta,Wilma E. Mesker,Marije Slingerland	2019	24
17	Geriatric assessment and 1‐year mortality in older patients with cancer in the head and neck region: A cohort study Head & Neck ·Floor J. van Deudekom,Lilly‐Ann van der Velden,Sarder Ahnaf Islam,J. Stehr,Dragos Titica,Marije Slingerland,Gerard J. Blauw,Simon P. Mooijaart	2019	24
18	Prophylactic antibiotics reduce hospitalisations and cost in locally advanced head and neck cancer patients treated with chemoradiotherapy: A randomised phase 2 study European Journal of Cancer ·Ayuni Riska Putri,C.M.L. Driessen,Mathijs P. Hendriks,E. Fiets,Bas Kreike,Ann Hoeben,Marije Slingerland,Augusto Cezar Braga Bagni,Bart Jan Kullberg,Marianne A. Jonker,Eddy Adang,J.H.A.M. Kaanders,Winette T.A. van der Graaf,Carla M. van Herpen	2019	10
19	Androgen deprivation therapy for androgen receptor‐positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The Netherlands Head & Neck ·Eline Boon,Wim van Boxtel,Jan Buter,Robert J. Baatenburg de Jong,Robert J.J. van Es,A.V. Galchuk,E. Fiets,Sjoukje F. Oosting,Marije Slingerland,Ann Hoeben,Margot Tesselaar,Marianne A. Jonker,Uta Flucke,(unknown),Winette T.A. van der Graaf,Carla M.L. van Herpen	2017	76
20	Liposomal drug formulations in cancer therapy: 15 years along the road Drug Discovery Today ·Marije Slingerland,Henk‐Jan Guchelaar,Hans Gelderblom	2011	191

About Marije Slingerland

Marije Slingerland is a scholar working on Geriatrics and Gerontology, Otorhinolaryngology and Oncology, having authored 88 papers that have together received 1.4k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (35 papers), Gastric Cancer Management and Outcomes (33 papers), Frailty in Older Adults (13 papers), Esophageal and GI Pathology (13 papers), Cancer Immunotherapy and Biomarkers (9 papers), Head and Neck Cancer Studies (9 papers), Lung Cancer Diagnosis and Treatment (7 papers) and Pancreatic and Hepatic Oncology Research (6 papers). The work is most often cited by research in Geriatrics and Gerontology (119 citations), Otorhinolaryngology (82 citations) and Biomaterials (244 citations). Marije Slingerland has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Hans Gelderblom, Henk‐Jan Guchelaar, Marc Diederich, Simon P. Mooijaart, Claudia Cerella, Floor J. van Deudekom, Rob H.A. Verhoeven, Hanneke W.M. van Laarhoven, Nadia Haj Mohammad and Laurens V. Beerepoot. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology, Journal of the National Comprehensive Cancer Network and Head & Neck.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact